The BOD had plenty of options to negotiate with Pfizer without...

First 547 Last

Share
Profile

Follow
asanque

204 Posts.

18

16/06/22

13:01

Post #: 62034868
Share

Originally posted by bajachris88: ↑

I don't feel it is right to criticise the BOD, as there may be an element of genius to these current events.

All those people saying "do the BOD think we're idiots; as if we're going to accept 11.5c!" etc.... what if the BOD was counting on you rejecting that price all along? ... Specifically, the BOD knew that 11.5c wouldn't be accepted, but played the 'right cards' so that the BOD could secure the addition funding from Pfizer, and commence a bidding game, given the opportunity presented itself?

And look at the outcomes; the game appears to be progressing well. Progressing is the key word, as the end-state isn't visible yet which means there is so much prospect still left.

Here's the progress so far; we got that additional funding (no need for CR), and the bid has now shifted from 11.5c to 20.7 (pending the report), and no final offer ceiling is visible yet. The BOD know its the SH that get the final say of what is the right value for the consensus, and this has always been the case through the voting requirement. Thus, how could the BOD ever shaft the majority of SH in the first place? BOD luring the big pharma fish with crumbs ...

When all is said and done, there is a great possibility that we will be well away from the original 11.5c offer; perhaps a thanks to the BOD may be better suited haha. I suggest all SH should attempt to rationalise this situation by considering the decision making processes deeper than just the surface of the water.

There's perception, psychology and strategy at play; the reaction of SH to the face-value of recent announcements is perhaps the desired reaction of the BOD to pressure Pfizer to lift their game by a long (nonetheless incremental) stretch, given Big Pharma need to win the hearts/minds of the voters.

My 2c...

Expand

The BOD had plenty of options to negotiate with Pfizer without embarrassing themselves by continually recommending low ball offers to shareholders.

Just reeks of taking the easy option.

RAP Price at posting: 16.5¢ Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

AAI

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

OPL

Opyl forms JV with UK and US consortium to bring products to the world

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas